To directly test the potential role of GPR17 in glioma development, we generated a stable GPR17-overexpressing cell line with a common used glioma cell line, U87MG (U87-GPR17) [25–27] (Fig. S2). The gene discussed is GPR17; the disease is central nervous system cancer.